ONESOURCE SPECIALTY PHARMA
Back to Cashflow Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-68 Cr | ₹-107 Cr | ₹-163 Cr | ₹-416 Cr |
What is the latest Cash Flow from Operating Activities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-68 Cr |
| Mar2024 | ₹-107 Cr |
| Mar2023 | ₹-163 Cr |
| Mar2022 | ₹-416 Cr |
How is Cash Flow from Operating Activities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-68 Cr | Negative | |
| Mar2024 | ₹-107 Cr | Negative | |
| Mar2023 | ₹-163 Cr | Negative | |
| Mar2022 | ₹-416 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,804.3 Cr | -7.8% | -4.6% | -22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -7.8% |
-4.6% |
-22.1% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses